Active Ingredient History

NOW
  • Now
NAMENDA (marketed under the brands Namenda among others) is an N-methyl-D-aspartate (NMDA) receptor antagonist indicated for the treatment of moderate to severe dementia of the Alzheimer’s type. Persistent activation of central nervous system N-methyl-D-aspartate (NMDA) receptors by the excitatory amino acid glutamate has been hypothesized to contribute to the symptomatology of Alzheimer’s disease. Memantine is postulated to exert its therapeutic effect through its action as a low to moderate affinity uncompetitive (open-channel) NMDA receptor antagonist which binds preferentially to the NMDA receptor-operated cation channels. There is no evidence that memantine prevents or slows neurodegeneration in patients with Alzheimer’s disease. Memantine showed low to negligible affinity for GABA, benzodiazepine, dopamine, adrenergic, histamine and glycine receptors and for voltage-dependent Ca2+, Na+ or K+ channels. Memantine also showed antagonistic effects at the 5HT3 receptor with a potency similar to that for the NMDA receptor and blocked nicotinic acetylcholine receptors with one-sixth to one-tenth the potency. In vitro studies have shown that memantine does not affect the reversible inhibition of acetylcholinesterase by donepezil, galantamine, or tacrine.   NCATS

More Chemistry

Drug Pricing (per unit)

United States

$0.0450 - $14.9009

Australia

$0.4181 - $0.8362
More Pricing Detail

Note: This drug pricing data is preliminary, incomplete, and may contain errors.

Combination drugs

1,3-dimethyl-5-adamantanamine | 1-amino-3,5-dimethyladamantane | 3,5-dimethyl-1-adamantanamine | 3,5-dimethyl-1-aminoadamantane | 3,5-dimethyltricyclo(3.3.1.1(3,7))decan-1-amine | akatinol | alzantin | ebixa | marixino | maruxa | memantina | memantine | memantine hcl | memantine hydrochloride | memantine hydrochloride / donepezil hydrochloride | memantinol | memantinum | memnatine | namenda | namenda xr | nemdatine | valios

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue